Literature DB >> 18194250

Plagiochin E, a botanic-derived phenolic compound, reverses fungal resistance to fluconazole relating to the efflux pump.

X-L Guo1, P Leng, Y Yang, L-G Yu, H-X Lou.   

Abstract

AIM: In this study, we investigated the effect of plagiochin E (PLE), a botanic-derived phenolic natural product, on reversal of fungal resistance to fluconazole (FLC) in vitro and the related mechanism. METHODS AND
RESULTS: A synergistic action of PLE and FLC was observed in the FLC-resistant Candida albicans strains and was evaluated using the fractional inhibited concentration index. The effect of PLE on FLC intracellular uptake was investigated in FLC-resistant C. albicans cells by liquid chromatography-tandem mass spectrometry, and the effect on efflux drug pump was assessed by measuring the efflux of Rhodamine 123 (Rh123). PLE significantly inhibited the efflux, but not the absorption, of Rh123 in FLC-resistant strains in phosphate-buffered saline with 5% glucose. Overexpression of the multidrug-resistance gene CDR1 in FLC-resistant C. albicans isolates was detected, and the introduction of PLE to the cells showed a significant reduction of the CDR1 expression in those FLC-resistant isolates.
CONCLUSIONS: These findings indicate that PLE could reverse the fungal resistant to FLC by inhibiting the efflux of FLC from C. albicans, and this effect may be related to the efflux pump. SIGNIFICANCE AND IMPACT OF THE STUDY: These results indicate that the combination of PLE and FLC may provide an approach for the clinical therapy of fungus infection induced by FLC-resistant strains.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18194250     DOI: 10.1111/j.1365-2672.2007.03617.x

Source DB:  PubMed          Journal:  J Appl Microbiol        ISSN: 1364-5072            Impact factor:   3.772


  13 in total

1.  Piperazinyl quinolines as chemosensitizers to increase fluconazole susceptibility of Candida albicans clinical isolates.

Authors:  Willmen Youngsaye; Benjamin Vincent; Cathy L Hartland; Barbara J Morgan; Sara J Buhrlage; Stephen Johnston; Joshua A Bittker; Lawrence MacPherson; Sivaraman Dandapani; Michelle Palmer; Luke Whitesell; Susan Lindquist; Stuart L Schreiber; Benito Munoz
Journal:  Bioorg Med Chem Lett       Date:  2011-06-30       Impact factor: 2.823

Review 2.  Targeting the fungal cell wall: current therapies and implications for development of alternative antifungal agents.

Authors:  Sahar Hasim; Jeffrey J Coleman
Journal:  Future Med Chem       Date:  2019-04-17       Impact factor: 3.808

3.  Overcoming fluconazole resistance in Candida albicans clinical isolates with tetracyclic indoles.

Authors:  Willmen Youngsaye; Chris Dockendorff; Benjamin Vincent; Cathy L Hartland; Joshua A Bittker; Sivaraman Dandapani; Michelle Palmer; Luke Whitesell; Susan Lindquist; Stuart L Schreiber; Benito Munoz
Journal:  Bioorg Med Chem Lett       Date:  2012-02-22       Impact factor: 2.823

4.  Ring strain and total syntheses of modified macrocycles of the isoplagiochin type.

Authors:  Andreas Speicher; Timo Backes; Kerstin Hesidens; Jürgen Kolz
Journal:  Beilstein J Org Chem       Date:  2009-12-01       Impact factor: 2.883

5.  Secondary Metabolites from Plants Inhibiting ABC Transporters and Reversing Resistance of Cancer Cells and Microbes to Cytotoxic and Antimicrobial Agents.

Authors:  Michael Wink; Mohamed L Ashour; Mahmoud Zaki El-Readi
Journal:  Front Microbiol       Date:  2012-04-23       Impact factor: 5.640

6.  Bisbibenzyls, a new type of antifungal agent, inhibit morphogenesis switch and biofilm formation through upregulation of DPP3 in Candida albicans.

Authors:  Li Zhang; Wenqiang Chang; Bin Sun; Matthias Groh; Andreas Speicher; Hongxiang Lou
Journal:  PLoS One       Date:  2011-12-12       Impact factor: 3.240

Review 7.  Natural Products as Alternative Choices for P-Glycoprotein (P-gp) Inhibition.

Authors:  Saikat Dewanjee; Tarun K Dua; Niloy Bhattacharjee; Anup Das; Moumita Gangopadhyay; Ritu Khanra; Swarnalata Joardar; Muhammad Riaz; Vincenzo De Feo; Muhammad Zia-Ul-Haq
Journal:  Molecules       Date:  2017-05-25       Impact factor: 4.411

8.  Synergistic in vitro activity of sodium houttuyfonate with fluconazole against clinical Candida albicans strains under planktonic growing conditions.

Authors:  Jing Shao; YanYan Cui; MengXiang Zhang; TianMing Wang; DaQiang Wu; ChangZhong Wang
Journal:  Pharm Biol       Date:  2017-12       Impact factor: 3.503

9.  ML212: A small-molecule probe for investigating fluconazole resistance mechanisms in Candida albicans.

Authors:  Willmen Youngsaye; Cathy L Hartland; Barbara J Morgan; Amal Ting; Partha P Nag; Benjamin Vincent; Carrie A Mosher; Joshua A Bittker; Sivaraman Dandapani; Michelle Palmer; Luke Whitesell; Susan Lindquist; Stuart L Schreiber; Benito Munoz
Journal:  Beilstein J Org Chem       Date:  2013-07-26       Impact factor: 2.883

10.  Synergistic antifungal effect of glabridin and fluconazole.

Authors:  Wei Liu; Li Ping Li; Jun Dong Zhang; Qun Li; Hui Shen; Si Min Chen; Li Juan He; Lan Yan; Guo Tong Xu; Mao Mao An; Yuan Ying Jiang
Journal:  PLoS One       Date:  2014-07-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.